Current Issue

Cancer Treatment Reviews

January 2022Volume 102

Current Issue Links

• Articles in Press
• Past Issues

Submit Mobile

• Submit article

Explore

• Subscribe
• Reprints
• Career Opportunities

Publish

• Submit Article
   
• Aims and Scope
• For Authors
• Supports Open Access
   

Connect

• Alerts
• Twitter
   

Articles in Press

• 
  Review article

  Open Access

  Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology

  Shah et al.

  Published online: January 5, 2022
• 
  Review article

  A comprehensive overview of tumour deposits in colorectal cancer: towards a next TNM classification

  Delattre et al.

  Published online: December 20, 2021

View All

Issue Highlights

• 

  Review articleOpen Access

  Quality-of-life methodology in hormone receptor–positive advanced breast cancer: Current tools and perspectives for the future

  Cardoso et al.

  Published online: November 17, 2021
• 

  Hot TopicOpen Access

  Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications

  Griguolo et al.

  Published online: December 2, 2021
• 

  Tumour Review

  SELNET clinical practice guidelines for soft tissue sarcoma and GIST

  Blay et al.

  Published online: November 13, 2021
• 

  Anti-tumour TreatmentOpen Access

  Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives

  Folprecht et al.

  Published online: November 10, 2021

About

Cancer Treatment Reviews

(Incorporating Evidence-based Oncology) is an international review journal that will keep both the clinician and researcher abreast of modern concepts and developments in cancer treatment research through the publication of state of the art, authoritative reviews; evidence-based reviews (using a priori defined selection process to identify key articles from the literature and reviewing them in the form of a structured abstract, evidence summary and commentary); and systematic reviews.

Metrics

Metrics

##

Impact Factor

##

5-Year Impact Factor

• More Journal Metrics
   
• Submit a Manuscript
   
• Top Social Media Articles
   
• Time to Online Publication
   

COVID-19

• 

  Complications of TreatmentOpen Access

  SARS-CoV-2 and cancer: Are they really partners in crime?

  van Dam et al.

  Published online: July 10, 2020
• Anti-tumour Treatment

  Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics

  Fares et al.

  Published online: June 29, 2020
• Hot Topic

  Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

  Fontana et al.

  Published online: June 10, 2020
• Hot Topic

  Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)

  Slimano et al.

  Published online: June 22, 2020
• 

  Hot Topic

  Cancer and COVID-19: Unmasking their ties

  Addeo et al.

  Published online: June 3, 2020
• 

  Systematic or Meta-analysis Studies

  The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

  Surujballi et al.

  Published online: March 23, 2021

Most Read (Last 30 Days)

• 
  Complications of Treatment

  Open Access

  Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities

  Bauer et al.

  Published online: November 30, 2021
• 
  Anti-tumour Treatment

  Open Access

  Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

  Garcia et al.

  Published online: March 26, 2020
• 
  Anti-tumour Treatment

  Open Access

  Immunotherapy in non-small cell lung cancer harbouring driver mutations

  Addeo et al.

  Published online: March 18, 2021
• 
  Anti-tumour Treatment

  Open Access

  Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives

  Folprecht et al.

  Published online: November 10, 2021
• 
  Review article

  Open Access

  KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond

  Nagasaka et al.

  Published online: October 20, 2021
• 
  Anti-tumour Treatment

  Open Access

  MYC as a target for cancer treatment

  Duffy et al.

  Published online: January 18, 2021

Most Cited (Previous 3 Years)

• Open Access

  Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

  • Garcia et al.

  Cancer Treatment Reviews, Vol.86, 102017

  June 2020

• Molecular targeted therapy of glioblastoma

  • Le Rhun et al.

  Cancer Treatment Reviews, Vol.80, 101896

  November 2019

• Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence

  • Raoul et al.

  Cancer Treatment Reviews, Vol.72, p28-36

  January 2019
• Open Access

  Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy

  • Ciardiello et al.

  Cancer Treatment Reviews, Vol.76, p22-32

  June 2019
• Open Access

  PARP inhibitors in ovarian cancer

  • Franzese et al.

  Cancer Treatment Reviews, Vol.73, p1-9

  February 2019

Tweets by OncologyAdvance